Literature DB >> 17494727

The Council for International Organizations and Medical Sciences (CIOMS) guidelines on ethics of clinical trials.

Duncan J Macrae1.   

Abstract

Numerous bodies from many countries, including governments, government regulatory departments, research organizations, medical professional bodies, and health care providers, have issued guidance or legislation on the ethical conduct of clinical trials. It is possible to trace the development of current guidelines back to the post-World War II Nuremburg war crimes trials, more specifically the "Doctors' Trial." From that trial emerged the Nuremburg Code, which set out basic principles to be observed when conducting research involving human subjects and which subsequently formed the basis for comprehensive international guidelines on medical research, such as the Declaration of Helsinki. Most recently, the Council for International Organizations and Medical Sciences (CIOMS) produced detailed guidelines (originally published in 1993 and updated in 2002) on the implementation of the principles outlined in the Declaration of Helsinki. The CIOMS guidelines set in an appropriate context the challenges of present-day clinical research, by addressing complex issues including HIV/AIDS research, availability of study treatments after a study ends, women as research subjects, safeguarding confidentiality, compensation for adverse events, as well guidelines on consent.

Entities:  

Mesh:

Year:  2007        PMID: 17494727     DOI: 10.1513/pats.200701-011GC

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  31 in total

1.  Navigating the challenges of global reproductive health research.

Authors:  Amy L Stenson; Chisina T Kapungu; Stacie E Geller; Suellen Miller
Journal:  J Womens Health (Larchmt)       Date:  2010-09-19       Impact factor: 2.681

2.  RNA-sequencing analysis reveals new alterations in cardiomyocyte cytoskeletal genes in patients with heart failure.

Authors:  Isabel Herrer; Esther Roselló-Lletí; Miguel Rivera; María Micaela Molina-Navarro; Estefanía Tarazón; Ana Ortega; Luis Martínez-Dolz; Juan Carlos Triviño; Francisca Lago; José R González-Juanatey; Vicente Bertomeu; José Anastasio Montero; Manuel Portolés
Journal:  Lab Invest       Date:  2014-04-07       Impact factor: 5.662

3.  ATP synthase subunit alpha and LV mass in ischaemic human hearts.

Authors:  Esther Roselló-Lletí; Estefanía Tarazón; María G Barderas; Ana Ortega; Maria Micaela Molina-Navarro; Alba Martínez; Francisca Lago; Luis Martínez-Dolz; Jose Ramón González-Juanatey; Antonio Salvador; Manuel Portolés; Miguel Rivera
Journal:  J Cell Mol Med       Date:  2014-11-09       Impact factor: 5.310

4.  Differential gene expression of cardiac ion channels in human dilated cardiomyopathy.

Authors:  Maria Micaela Molina-Navarro; Esther Roselló-Lletí; Ana Ortega; Estefanía Tarazón; Manuel Otero; Luis Martínez-Dolz; Francisca Lago; José Ramón González-Juanatey; Francisco España; Pablo García-Pavía; José Anastasio Montero; Manuel Portolés; Miguel Rivera
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

5.  Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.

Authors:  María Micaela Molina-Navarro; Juan Carlos Triviño; Luis Martínez-Dolz; Francisca Lago; Jose Ramón González-Juanatey; Manuel Portolés; Miguel Rivera
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

6.  Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy.

Authors:  Isabel Herrer; Esther Roselló-Lletí; Ana Ortega; Estefanía Tarazón; María Micaela Molina-Navarro; Juan Carlos Triviño; Luis Martínez-Dolz; Luis Almenar; Francisca Lago; Ignacio Sánchez-Lázaro; José Ramón González-Juanatey; Antonio Salvador; Manuel Portolés; Miguel Rivera
Journal:  BMC Med Genomics       Date:  2015-03-29       Impact factor: 3.063

7.  Heart failure induces significant changes in nuclear pore complex of human cardiomyocytes.

Authors:  Estefanía Tarazón; Miguel Rivera; Esther Roselló-Lletí; Maria Micaela Molina-Navarro; Ignacio José Sánchez-Lázaro; Francisco España; José Anastasio Montero; Francisca Lago; José Ramón González-Juanatey; Manuel Portolés
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

Review 8.  Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.

Authors:  Sharon Nachman; Amina Ahmed; Farhana Amanullah; Mercedes C Becerra; Radu Botgros; Grania Brigden; Renee Browning; Elizabeth Gardiner; Richard Hafner; Anneke Hesseling; Cleotilde How; Patrick Jean-Philippe; Erica Lessem; Mamodikoe Makhene; Nontombi Mbelle; Ben Marais; Helen McIlleron; David F McNeeley; Carl Mendel; Stephen Murray; Eileen Navarro; E Gloria Anyalechi; Ariel R Porcalla; Clydette Powell; Mair Powell; Mona Rigaud; Vanessa Rouzier; Pearl Samson; H Simon Schaaf; Seema Shah; Jeff Starke; Soumya Swaminathan; Eric Wobudeya; Carol Worrell
Journal:  Lancet Infect Dis       Date:  2015-05-06       Impact factor: 25.071

9.  RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.

Authors:  Estefanía Tarazón; Esther Roselló-Lletí; Miguel Rivera; Ana Ortega; Maria Micaela Molina-Navarro; Juan Carlos Triviño; Francisca Lago; José Ramón González-Juanatey; Placido Orosa; José Anastasio Montero; Antonio Salvador; Manuel Portolés
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Endoplasmic reticulum stress induces different molecular structural alterations in human dilated and ischemic cardiomyopathy.

Authors:  Ana Ortega; Esther Roselló-Lletí; Estefanía Tarazón; Maria Micaela Molina-Navarro; Luis Martínez-Dolz; José Ramón González-Juanatey; Francisca Lago; Jose David Montoro-Mateos; Antonio Salvador; Miguel Rivera; Manuel Portolés
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.